Extracell Biotechnologies SRL
Extracell Biotechnologies reported revenue of 7,500 € for the 2025 financial year (annual accounts filed with the NBB on 30 Jul 2026).
The score of Extracell Biotechnologies shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Total assets -94 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Extracell Biotechnologies's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jul 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 01 Apr 2025
Extracell Biotechnologies's financial analysis
Management and control of Extracell Biotechnologies
Extracell Biotechnologies's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0804.532.945
- VAT number
- BE0804532945
- Peppol
- Registered · 0208:0804532945 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Aug 2023
- Registered office
- 4031 Liège
- Latest accounts
- 2025 · filed on 30 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Extracell Biotechnologies (SRL) has been based in Liège since 2023, active in: research and experimental development on biotechnology. For 2025, it reports revenue of 7,500 €, a net loss of 1,898 € and equity of −8,397 €.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Extracell Biotechnologies
Companies in the same business, of comparable size and area, outside its group.
- Grand Medical (Europe) Research and experimental development on natural sciences and engineering Niel · balance sheet 135,260 €
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- Organic Molecules Networks for the Industrial Sector Research and experimental development on natural sciences and engineering Visé · balance sheet 2,460 €
- OncoRNA Research and experimental development on natural sciences and engineering Charleroi · balance sheet 20,034 €
- Nanogyre Research and experimental development on natural sciences and engineering Liège · balance sheet 22,232 €
- Phages Adepte Research and experimental development on natural sciences and engineering Forest · balance sheet 18,274 €
- Lipofabrik Belgium Research and experimental development on natural sciences and engineering Gembloux · balance sheet 23,877 €
- RheADC Manufacture of basic pharmaceutical products Leuven · balance sheet 31,395 €
Frequently asked questions about Extracell Biotechnologies
What is the revenue of Extracell Biotechnologies?
According to the 2025 annual accounts filed with the NBB, the revenue of Extracell Biotechnologies amounts to 7,500 €.
What is the VAT number of Extracell Biotechnologies?
In Belgium, the VAT number is the company number prefixed with BE: BE0804532945 for Extracell Biotechnologies, if the company is VAT-registered. Its company number (CBE) is 0804.532.945.
Where is the registered office of Extracell Biotechnologies?
According to the CBE register, the registered office of Extracell Biotechnologies is in 4031 Liège.
Who manages Extracell Biotechnologies?
The register lists 2 active mandates at Extracell Biotechnologies. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Extracell Biotechnologies
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →